The pharmaceutical companies said they would begin talks even as several of them were suing the Biden administration over a new law authorizing the negotiations.
read more
McCarthy’s Ouster Adds to Market Jitters
13:44, October 4, 2023
Andrew Ross Sorkin, Ravi Mattu, Bernhard Warner, Sarah Kessler, Michael J. de la Merced, Lauren Hirsch and Ephrat Livni